Caso contributivo
Una enterocolite da Campylobacter jejuni che confonde
A Campylobacter jejuni enteritis that baffles
Alessandra Iacono*, Claudia Guiducci*, Martina Mainetti, Silvia Brocchi, Federico Marchetti
UOC di Pediatria e Neonatologia, Ospedale di Ravenna, AUSL della Romagna
*Scuola di specializzazione in Pediatria, Università di Ferrara
Gennaio 2019
Abstract
Campylobacter infection is one of the most frequent enteritis in developed countries and in most cases it features a self-limiting character. In some cases it shows severe clinical pictures and it requires antibiotic therapy. Cases of antibiotic resistance are emerging, especially against fluoroquinolone. The article presents a case of a 14-year-old boy with a febrile Campylobacter enteritis treated with ceftriaxone and ciprofloxacin with an immediate resolution of the symptoms. Ten days later, the boy still showed the same symptoms suggesting three hypotheses: 1) failure of Campylobacter’s eradication; 2) abdominal abscess; 3) beginning of inflammatory bowel disease associated with a concomitant and confusing Campylobacter jejuni infection. Coproculture still showed the presence of Campylobacter, and the treatment with azithromycin was effective in eradicating the infection. Past history and complete negativity of inflammatory index and faecal calprotectin allowed an inflammatory bowel disease to be excluded.
Contenuto riservato
Per leggere l'articolo è necessario effettuare il login.
Per l'acquisto del singolo articolo scrivi a
abbonamenti@medicoebambino.com
(la mail si prepara da sola con gli estremi dell'articolo);
se accedi, la richiesta parte con un click.
Classificazione MeSH
Bibliografia
- Istituto Superiore di Sanità. Campylobacter.
- Allos BM. Campylobacter jejuni infections: update on emerging issues and trends. Clin Infect Dis 2001;32(8):1201-6.
- Kaakoush NO, Castaño-Rodríguez N, Mitchell HM, Man SM. Global epidemiology of Campylobacter infection. Clin Microbiol Rev 2015;28(3):687-720.
- Pope JE, Krizova A, Garg AX, Thiessen-Philbrook H, Ouimet JM. Campylobacter reactive arthritis: a systematic review. Semin Arthritis Rheum 2007;37(1):48-55.
- Mortensen NP, Kuijf ML, Ang CW, et al. Sialylation of Campylobacter jejuni lipo-oligosaccharides is associated with severe gastro-enteritis and reactive arthritis. Microbes Infect 2009;11(12):988-94.
- Rautelin H, Koota K, von Essen R, Jahkola M, Sitonen A, Kosunen TU. Waterborne Campylobacter jejuni epidemic in a Finnish hospital for rheumatic diseases. Scand J Infect Dis 1990;22(3):321-6.
- Butzler JP. Campylobacter, from obscurity to celebrity. Clin Microbiol Infect 2004;10(10):868-76.
- American Academy of Pediatrics. Kimberlin DW, Brady MT, Jackson MA, Long SS (eds). Red Book 2015. Committee on Infectious Diseases 2015, pagg. 273-5.
- Luangtongkum T, Jeon B, Han J, Plummer P, Logue CM, Zhang Q. Antibiotic resistance in Campylobacter: emergence, transmission and persistence. Future Microbiol 2009;4(2):189-200.
- O’Hara GA, Fitchett JRA, Klein JL. Campylobacter bacteremia in London: A 44-year single-Center study. Diagn Microbiol Infect Dis 2017;89(1):67-71.
- Zautner AE, Johann C, Strubel A, et al. Seroprevalence of campylobacteriosis and relevant post-infectious sequelae. Eur J Clin Microbiol Infect Dis 2014;33(6):1019-27.
- Akar M, Aydin F, Yurci MA, Abay S, Deniz K. The possible relationship between Campylobacter spp. / Arcobacter spp. and patients with ulcerative colitis. Eur J Gastroenterol Hepatol 2018;30(5):531-8.
- Man SM, Kaakoush NO, Mitchell HM. The role of bacteria and pattern-recognition receptors in Crohn’s disease. Nat Rev Gastroenterol Hepatol 2011;8(3):152-68.